Evogene Ltd (EVGN)
0.8499
+0.15
(+21.41%)
USD |
NASDAQ |
May 10, 12:39
Evogene Total Liabilities (Quarterly): 22.42M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 22.42M |
| September 30, 2023 | 21.88M |
| June 30, 2023 | 22.23M |
| March 31, 2023 | 20.98M |
| December 31, 2022 | 21.34M |
| September 30, 2022 | 21.09M |
| June 30, 2022 | 11.26M |
| March 31, 2022 | 12.15M |
| December 31, 2021 | 12.88M |
| September 30, 2021 | 12.63M |
| June 30, 2021 | 10.89M |
| March 31, 2021 | 10.67M |
| December 31, 2020 | 15.03M |
| September 30, 2020 | 9.915M |
| June 30, 2020 | 10.13M |
| March 31, 2020 | 9.708M |
| December 31, 2019 | 11.15M |
| September 30, 2019 | 10.31M |
| June 30, 2019 | 10.60M |
| March 31, 2019 | 10.88M |
| December 31, 2018 | 8.388M |
| September 30, 2018 | 7.891M |
| Date | Value |
|---|---|
| June 30, 2018 | 8.137M |
| March 31, 2018 | 7.702M |
| December 31, 2017 | 8.224M |
| September 30, 2017 | 8.10M |
| June 30, 2017 | 8.111M |
| March 31, 2017 | 8.594M |
| December 31, 2016 | 8.697M |
| September 30, 2016 | 8.503M |
| June 30, 2016 | 8.246M |
| March 31, 2016 | 7.695M |
| December 31, 2015 | 8.843M |
| September 30, 2015 | 8.275M |
| June 30, 2015 | 9.509M |
| March 31, 2015 | 9.756M |
| December 31, 2014 | 11.50M |
| September 30, 2014 | 9.476M |
| June 30, 2014 | 10.03M |
| March 31, 2014 | 10.04M |
| December 31, 2013 | 12.56M |
| September 30, 2013 | 13.26M |
| June 30, 2013 | 14.70M |
| December 31, 2012 | 16.60M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
9.708M
Minimum
Mar 2020
22.42M
Maximum
Dec 2023
14.59M
Average
12.15M
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Compugen Ltd | 55.78M |
| Pluri Inc | 34.95M |
| BioLine Rx Ltd | 50.70M |
| Can Fite Biofarma Ltd | 3.746M |
| BiomX Inc | 21.95M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 51.10M |
| Shareholders Equity (Quarterly) | 12.05M |
| Debt to Equity Ratio | 0.8602 |
| Current Ratio | 4.964 |
| Net Debt Paydown Yield | -0.17% |